Economy

Economy Latest News

AstraZeneca to invest $50 bn in the US as tariff threat looms
AstraZeneca to invest $50 bn in the US as tariff threat looms
by  AFP

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald Trump's threats to impose tariffs on the sector. The United States is a key market for the pharmaceutical industry, and AstraZeneca said it expects 50 percent of its revenue to come from the US by 2030.

Price hikes nibble at demand for Lindt chocolate
Price hikes nibble at demand for Lindt chocolate
by  AFP

Premium Swiss chocolate maker Lindt & Sprungli hiked its 2025 sales target as cocoa price hikes passed on to customers outweighed a drop in volumes. While sales volumes declined by 4.6 percent, it still saw revenues climb by nine percent to 2.4 billion Swiss francs ($3.0 billion) as consumers continued to buy chocolate despite the price hikes.

UK gives green light to £38 bn Sizewell C nuclear plant
UK gives green light to £38 bn Sizewell C nuclear plant
by  AFP

The UK government on Tuesday gave new British nuclear power plant Sizewell C the final go-ahead, after it struck a deal with investors, in a move to bolster energy security. The UK has refocused on shoring up nuclear power since the start of the war in Ukraine, in the name of energy security and faced with a fleet of ageing power stations.

AstraZeneca says to invest $50 bn in the US
AstraZeneca says to invest $50 bn in the US
by  AFP

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington. The United States is a key market for the pharmaceutical industry, and AstraZeneca had already announced in April that it had begun transferring part of its European production to the United States.

Page was generated in 0.08017110824585